Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: The Clinical Outcomes with Montelukast as a Partner Agent to Corticosteroid Therapy (COMPACT) trial demonstrated that montelukast added to budesonide (MNT + BD) was as efficacious as double the dose of budesonide (dBD) in improving morning peak expiratory flow (AM PEF) in adult asthmatics. Recent studies have demonstrated that montelukast is also effective in treating daytime and nighttime allergic rhinitis (AR) symptoms in asthmatic patients. This analysis was designed to examine whether asthmatic patients with comorbid AR respond differently than patients without comorbid AR in terms of asthma control (lung function). Methods: There were 216 asthmatic patients in the MNT + BD group and 184 patients in the dBD group with AR. Treatment differences in the change from baseline in AM PEF were compared. Least square (LS) mean and 95% confidence interval (CI) were derived from an anova model adjusting for baseline and study site. Results: There was a 9.2% increase in AM PEF from baseline in the MNT + BD group compared with a 6% increase in the dBD group. The LS mean difference [(MNT + BD) − dBD] was 14.2 l/min (P = 0.028). Other secondary endpoints were similar between groups. Conclusion: In the subgroup of asthmatic patients with AR, a combined treatment approach that included montelukast and budesonide provided significantly greater efficacy in reducing airflow obstruction compared with doubling the dose of budesonide. These results support recommendations by the Allergic Rhinitis and its Impact on Asthma initiative that suggest a unified approach aimed at treating the airway inflammation common to both diseases is beneficial for the large proportion of asthmatics who also suffer from AR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Allergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
Segmental Bronchial Provocation Induces Nasal Inflammation in Allergic Rhinitis Patients
BRAUNSTAHL, G.-J., KLEINJAN, A., OVERBEEK, S. E., PRINS, J.-B., HOOGSTEDEN, H. C., & FOKKENS, W. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.6.9906121 · Cited by 399 · cited 1×
“Similarly, allergen challenge to the lung leads to inflammation in the nose (7).”
BackgroundEffect of a concomitant diagnosis of allergic rhinitis on asthma‐related health care use by adults
Price, D., Zhang, Q., Kocevar, V. S., Yin, D. D., & Thomas, M. (2005) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2005.02182.x · Cited by 205
Self-citation
Cited by
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
Bousquet, J., Khaltaev, N., Cruz, A. A., Denburg, J., Fokkens, W. J., Togias, A., Zuberbier, T., Baena‐Cagnani, C. E., Canonica, G. W., Van Weel, C., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01620.x · Cited by 4,729
“In the COMPACT trial, in a subgroup of asthmatic patients with allergic rhinitis, a combined treatment approach that included montelukast and budesonide provided significantly greater efficacy in reducing airflow obstruction when compared to doubling the dose of budesonide (2034).”
Self-citationAllergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
Brożek, J. L., Bousquet, J., Baena-Cagnani, C. E., Bonini, S., Canonica, G. W., Casale, T. B., van Wijk, R. G., Ohta, K., Zuberbier, T., & Schünemann, H. J. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.06.047 · Cited by 1,813
“In the COMPACT trial, in a subgroup of asthmatic patients with allergic rhinitis, a combined treatment approach that included montelukast and budesonide provided significantly greater efficacy in reducing airflow obstruction when compared to doubling the dose of budesonide (2034).”
The diagnosis and management of rhinitis: An updated practice parameter
WALLACE, D., DYKEWICZ, M., BERNSTEIN, D., BLESSINGMOORE, J., COX, L., KHAN, D., LANG, D., NICKLAS, R., OPPENHEIMER, J., & PORTNOY, J. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.06.003 · Cited by 1,096
Peters-Golden, M., & Henderson, W. R. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071371 · Cited by 1,013
Brand, P. L. P., Baraldi, E., Bisgaard, H., Boner, A. L., Castro-Rodriguez, J. A., Custovic, A., de Blic, J., de Jongste, J. C., Eber, E., Everard, M. L., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00002108 · Cited by 857
Metadata
- Authors
- Price, D. B., Swern, A., Tozzi, C. A., Philip, G., & Polos, P.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2006-05-05
- Volume
- 61
- Issue
- 6
- Pages
- 737-742
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W1979192746
- Cited by
- 122
- References
- 3
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial. https://app.cochat.ai/papers/10.1111/j.1398-9995.2006.01007.x
- The paper
- Price, D. B., Swern, A., Tozzi, C. A., Philip, G., & Polos, P. (2006). Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial. Allergy. https://doi.org/10.1111/j.1398-9995.2006.01007.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.